Li Zhu

<i>In Vitro</i>Antiviral Characteristics of HIV-1 Attachment Inhibitor BMS-626529, the Active Component of the Prodrug BMS-663068

Beata Nowicka-Sans, Yi-Fei Gong, Brian McAuliffe et al. · Antimicrobial Agents and Chemotherapy · 2012 · 138 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Pharmacodynamics, Safety, and Pharmacokinetics of BMS-663068, an Oral HIV-1 Attachment Inhibitor in HIV-1-Infected Subjects

Richard E. Nettles, Dirk Schürmann, Li Zhu et al. · The Journal of Infectious Diseases · 2012 · 106 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

A Nucleoside- and Ritonavir-Sparing Regimen Containing Atazanavir Plus Raltegravir in Antiretroviral Treatment-Naïve HIV-Infected Patients: SPARTAN Study Results

Michael J. Kozal, Sergio Lupo, Edwin DeJesus et al. · HIV Clinical Trials · 2012 · 85 citations

Medicine, Pharmacology, Pharmacotherapy +17

Compartmental Absorption Modeling and Site of Absorption Studies to Determine Feasibility of an Extended-Release Formulation of an HIV-1 Attachment Inhibitor Phosphate Ester Prodrug

Jonathan Brown, Caly Chien, Peter Timmins et al. · Journal of Pharmaceutical Sciences · 2013 · 58 citations

Pharmacy, Pharmaceutics, Pharmacokinetics +17

Therapeutic drug monitoring and safety of voriconazole therapy in patients with Child–Pugh class B and C cirrhosis: A multicenter study

Taotao Wang, Miao Yan, Dan Tang et al. · International Journal of Infectious Diseases · 2018 · 55 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +11